SCHEMBL3075841

SCHEMBL3075841

Cc1n[nH]c(C)c1-c1ccc(Cl)c(C#N)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 2/20 0.49
CHEK1 O14757 2/20 0.46
AKT2 P31751 1/20 0.46
ACVR1 Q04771 1/20 0.42
OTUD7B Q6GQQ9 2/20 0.40
CHUK O15111 2/20 0.40
AURKA O14965 2/20 0.40
PLK4 O00444 1/20 0.40
ROCK2 O75116 1/20 0.40
CHEK2 O96017 1/20 0.40
INSR P06213 1/20 0.40
CDK1 P06493 1/20 0.40
CSF1R P07333 1/20 0.40
PIM1 P11309 1/20 0.40
FGFR1 P11362 1/20 0.40
PRKACA P17612 1/20 0.40
FLT1 P17948 1/20 0.40
FGFR3 P22607 1/20 0.40
RPS6KB1 P23443 1/20 0.40
CDK2 P24941 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3076212 0.88 IKBKB (0.49) IKBKBCHEK1AKT2ACVR1OTUD7B
SCHEMBL3080716 0.79 CYP11B1 (0.50) CHEK1AKT2ACVR1
SCHEMBL3083270 0.77 KDM4E (0.51) CHEK1AKT2ACVR1ROCK2ROCK1
SCHEMBL3075671 0.76 AR (0.57) CHEK1AKT2
SCHEMBL22704005 0.75 AR (0.39) IKBKBCHEK1AKT2ACVR1OTUD7B
SCHEMBL3074271 0.74 CHEK1 (0.59) IKBKBCHEK1AKT2ACVR1OTUD7B
SCHEMBL3081390 0.74 ALDH1A1 (0.38) IKBKBCHEK1AKT2AURKATPX2
SCHEMBL16209719 0.73 AKT2 (0.79) IKBKBCHEK1AKT2ACVR1CHUK
SCHEMBL22524443 0.73 AR (0.37) IKBKBCHEK1AKT2FASNBRD4
SCHEMBL30545918 0.73 AR (0.37) IKBKBCHEK1AKT2FASNBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101842357-A Substituted pyrazole derivatives TAKEDA PHARMACEUTICAL 2010-09-22 CN disclosed
US-20100227846-A1 SUBSTITUTED PYRAZOLE DERIVATIVE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-09-09 US disclosed
US-20100227846-A1 SUBSTITUTED PYRAZOLE DERIVATIVE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-09-09 US disclosed
US-20100227846-A1 SUBSTITUTED PYRAZOLE DERIVATIVE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-09-09 US disclosed
EP-2194045-A1 SUBSTITUTED PYRAZOLE DERIVATIVE Takeda Pharmaceutical Company Limited (JP) 2010-06-09 EP disclosed
EP-2194045-A1 SUBSTITUTED PYRAZOLE DERIVATIVE Takeda Pharmaceutical Company Limited (JP) 2010-06-09 EP disclosed
US-20090270359-A1 SUBSTITUTED PYRAZOLE DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-10-29 US disclosed
US-20090270359-A1 SUBSTITUTED PYRAZOLE DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-10-29 US disclosed
US-20090270359-A1 SUBSTITUTED PYRAZOLE DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100227846-A1 SUBSTITUTED PYRAZOLE DERIVATIVE AR, NR5A1, NR3C2 IKBKB 2703/4885CHEK1 1685/4885AKT2 1615/4885
US-20090270359-A1 SUBSTITUTED PYRAZOLE DERIVATIVES AR, NR5A1, NR3C2 IKBKB 2688/4885CHEK1 1722/4885AKT2 1611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.